BioCentury
ARTICLE | Clinical News

Proellex telapristone: Phase II data

September 26, 2016 7:00 AM UTC

Top-line data from a double-blind, U.S. and Argentinian Phase II trial in 60 premenopausal patients with moderate to severe confirmed symptomatic endometriosis showed that once-daily 6 and 12 mg oral ...